01621nam 2200421 a 450 991069577750332120070322102646.0(CKB)5470000002372003(OCoLC)86106712(EXLCZ)99547000000237200320070322d2007 ua 0engurmn|---|||||txtrdacontentcrdamediacrrdacarrierPrescription drugs[electronic resource] oversight of drug pricing in federal programs : testimony before the Committee on Oversight and Government Reform, House of Representatives /statement of John E. Dicken[Washington, D.C.] :U.S. Government Accountability Office,[2007]13 pages digital, PDF fileTestimony ;GAO-07-481 TTitle from title screen (viewed on Mar. 8, 2006)."For release ... February 9, 2007."Paper version available from: U.S. Government Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.Includes bibliographical references.Prescription drugs DrugsPricesUnited StatesMedicareDrugsPricesMedicare.Dicken John E1382684United States.Congress.House.Committee on Government Reform and Oversight.United States.Government Accountability Office.GPOGPOBOOK9910695777503321Prescription drugs3435639UNINA